April pub med:
Expert opinion: Continued improvements in delivery technology, in particular electroporation, and the use of prime-boost vaccine strategies will aid in boosting the immunogenicity of DNA vaccines.
This looks like more of an overview than actual results. Aren't we still waiting for the results?
Sentiment: Strong Buy
April...between now the bioccentury conference on the 5th and the world vaccine conference on the 18th
Kyle, why do you say April? Seems reasonable, but what are your reasons? Isn't it completely out of the hands of the company?